Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

OBJECTIVE: Prostate secretory protein of 94 amino acids (PSP94) is a target gene of the EZH2 transcriptional repressor and is often downregulated in prostate cancer; however, its prognostic value is disputed. METHODS: Immunohistochemical analysis of a tissue microarray of 12, 432 prostate cancer spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Luebke, Andreas M., Attarchi-Tehrani, Ali, Meiners, Jan, Hube-Magg, Claudia, Lang, Dagmar S., Kluth, Martina, Tsourlakis, Maria Christina, Minner, Sarah, Simon, Ronald, Sauter, Guido, Büscheck, Franziska, Jacobsen, Frank, Hinsch, Andrea, Steurer, Stefan, Schlomm, Thorsten, Huland, Hartwig, Graefen, Markus, Haese, Alexander, Heinzer, Hans, Clauditz, Till S., Burandt, Eike, Wilczak, Waldemar, Höflmayer, Doris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713635/
https://www.ncbi.nlm.nih.gov/pubmed/31516752
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713635/
https://www.ncbi.nlm.nih.gov/pubmed/31516752
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0384

Ejemplares similares